Bloomberg announced that Annie Lamont, the First Lady of Connecticut, will join its new Board of Directors.
Annie sure has the Midas touch when it comes to her company Oak HC/FT, a $3.3 billion venture capital firm that she co-founded in 2014 to invest exclusively in healthcare and fintech entrepreneurs.
Many people immediately think of the Sema4 covid testing controversy when they hear the name of Annie’s firm mentioned.
The State of Connecticut paid Sema4 $23 million dollars for a no bid contract for covid testing during the pandemic. Of course, many people will also recall that covid testing was required by the Lamont Administration at the time. Yet somehow Lamont, who made $54 million while in office as governor, managed to escape ethics concerns over this very suspicious arrangement with his wife's company. It is unclear how much Annie made off the deal.
More recently, in August 2023, Annie earned the nickname "Saudi Annie" after it became public knowledge that her company, Oak HC/FT, has been in an investment partnership with Sanabil Investments, a Saudi Arabia-owned investment firm. The firm is a wholly-owned company by Public Investment Fund (PIF), one of the largest sovereign wealth funds in the world, with estimated assets of US$700 billion.
Annie currently serves on a number of other boards, including Advise Health Holdings, Brightline, CareBridge, Main Street Health, Modern Age, Quartet, Rubicon Founders, Truepill, Vesta Health and VillageMD. She is a Board Observer at Precision Medicine Group. Annie has also served on the Board of Trustees at Stanford University.